Biochemical characterisation and genetic analysis of aureocin A53, a new, atypical bacteriocin from Staphylococcus aureus.
about
Genomics of Actinobacteria: tracing the evolutionary history of an ancient phylumIdentification of Bacillus subtilis sigma-dependent genes that provide intrinsic resistance to antimicrobial compounds produced by BacilliStructural analysis and characterization of lacticin Q, a novel bacteriocin belonging to a new family of unmodified bacteriocins of gram-positive bacteria.Impact of Staphylococcus aureus on pathogenesis in polymicrobial infections.Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against Staphylococci2-Aminobenzamide and 2-aminobenzoic acid as new MALDI matrices inducing radical mediated in-source decay of peptides and proteins.Genetics of antimicrobial resistance in Staphylococcus aureus.Complete sequence of the enterocin Q-encoding plasmid pCIZ2 from the multiple bacteriocin producer Enterococcus faecium L50 and genetic characterization of enterocin Q production and immunity.Genetic analysis of bacteriocin 43 of vancomycin-resistant Enterococcus faecium.Production of bacteriocin by Virgibacillus salexigens isolated from "terasi": a traditionally fermented shrimp paste in Indonesia.A peptide factor secreted by Staphylococcus pseudintermedius exhibits properties of both bacteriocins and virulence factors.Identification and classification of known and putative antimicrobial compounds produced by a wide variety of Bacillales species.Mapping the pathways to staphylococcal pathogenesis by comparative secretomicsBacteriocin diversity in Streptococcus and Enterococcus.Isolation, biochemical characterization, and cloning of a bacteriocin from the poultry-associated Staphylococcus aureus strain CH-91.Ribosomal peptide natural products: bridging the ribosomal and nonribosomal worlds.New type non-lantibiotic bacteriocins: circular and leaderless bacteriocins.Mode of action of the antimicrobial peptide aureocin A53 from Staphylococcus aureus.Genes involved in immunity to and secretion of aureocin A53, an atypical class II bacteriocin produced by Staphylococcus aureus A53.An accessory protein is required for relaxosome formation by small staphylococcal plasmids.Purification and Molecular Characterization of the Novel Highly Potent Bacteriocin TSU4 Produced by Lactobacillus animalis TSU4.High Throughput Identification of Antimicrobial Peptides from Fish Gastrointestinal Microbiota.Investigating the basis of substrate recognition in the pC221 relaxosome.Revealing the latent mobilization capability of the staphylococcal bacteriocinogenic plasmid pRJ9.Lactolisterin BU, a Novel Class II Broad-Spectrum Bacteriocin from Lactococcus lactis subsp. lactis bv. diacetylactis BGBU1-4.Bacteriocins as alternative agents for control of multiresistant staphylococcal strains.Characterization and purification of a bacteriocin from Lactobacillus paracasei subsp. paracasei BMK2005, an intestinal isolate active against multidrug-resistant pathogens.Bacteriocin production of the probiotic Lactobacillus acidophilus KS400
P2860
Q24681753-8E7DFD81-4C01-4CBE-80F1-3B1140B2D061Q28489040-19466999-9139-4164-8EA5-4E3937880536Q33277818-7118B503-2695-42DE-9ADE-009B3A97B138Q33602984-ADE1BBB5-F70B-48D6-A104-01C68A7B1238Q34095875-4E88473C-5118-477B-8A9F-C516F7D70F6AQ34106416-05B9DC4A-8428-49F3-B2BE-3D0E2C32C629Q34984662-0F8F8596-2A0F-4ACD-B034-B095E84E75C0Q35091829-143DB3D9-1AE7-43CE-8B22-768AA6665AB9Q35130004-3530CF57-F012-4512-81C9-DC055CB3A040Q35923015-C565BEEC-BBFD-417D-B9D9-D5283E2CCB24Q36100083-EA63F536-DDDC-456D-89CD-EEC95195AFB5Q36184507-06CC8584-7F3F-4A8E-B2F6-46652A862935Q36588782-CD663276-2AE8-4634-A2B7-BECA77AE34F5Q36651005-19982FD1-9239-4523-B476-1007C3611839Q37049158-5A98C20A-B449-4404-9E4E-6BA6904ED681Q37566506-600CE00B-F58C-441D-9B0E-A00D3AC944F4Q37986266-58ECC931-186B-4B9C-B975-17D9DD3E6EF9Q39661669-95BE90E3-3523-41BE-B0EA-08F9430B6A94Q40870805-09C6EF56-A212-46BF-85AD-671AD9FCC526Q40883375-77A64335-0E51-482B-9C65-B0BAA224AC88Q41070614-062A3047-2BF6-4AC5-9D9C-449D78884F0AQ41669320-27498D84-1777-43C7-8FDE-CB1A3D809B78Q42218598-EEFC2EE0-06FF-4CA7-91A1-B743FA0D400EQ45865549-26325C93-5184-44E2-9AFD-FD204C12F3B0Q46316116-4C098C17-75C6-404F-94C8-7120869915A4Q46944695-48A15323-BE3E-46EF-B7D9-5F18812512DEQ48047946-94B9C1B4-4DD3-42B9-BCF3-4A7BFBEFA560Q59129258-29498023-CB60-472A-B745-72E108FE16F7
P2860
Biochemical characterisation and genetic analysis of aureocin A53, a new, atypical bacteriocin from Staphylococcus aureus.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Biochemical characterisation a ...... in from Staphylococcus aureus.
@ast
Biochemical characterisation a ...... in from Staphylococcus aureus.
@en
type
label
Biochemical characterisation a ...... in from Staphylococcus aureus.
@ast
Biochemical characterisation a ...... in from Staphylococcus aureus.
@en
prefLabel
Biochemical characterisation a ...... in from Staphylococcus aureus.
@ast
Biochemical characterisation a ...... in from Staphylococcus aureus.
@en
P2093
P1476
Biochemical characterisation a ...... cin from Staphylococcus aureus
@en
P2093
Annette G Beck-Sickinger
Daili Jacqueline Aguilar Netz
Hans-Georg Sahl
Maria do Carmo de Freire Bastos
Regula Pohl
Thorsten Selmer
P304
P356
10.1016/S0022-2836(02)00368-6
P407
P577
2002-06-01T00:00:00Z